ArticleCancer science2013

Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)-reactivating agents enhance efficacy of 5-fluorouracil on human colon cancer cells.

Motoki Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.